{"id":"https://openalex.org/W104990378","doi":"https://doi.org/10.1007/978-3-319-06752-0_2","title":"Resistance to Proteasome Inhibitors in Multiple Myeloma","display_name":"Resistance to Proteasome Inhibitors in Multiple Myeloma","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W104990378","doi":"https://doi.org/10.1007/978-3-319-06752-0_2","mag":"104990378"},"language":"en","primary_location":{"id":"doi:10.1007/978-3-319-06752-0_2","doi":"https://doi.org/10.1007/978-3-319-06752-0_2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-3-319-06752-0_2","pdf_url":null,"source":{"id":"https://openalex.org/S4210200539","display_name":"Resistance to targeted anti-cancer therapeutics","issn_l":"2196-5501","issn":["2196-5501","2196-551X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319972","host_organization_name":"Springer International Publishing","host_organization_lineage":["https://openalex.org/P4310319972","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer International Publishing","Springer Nature"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Resistance to Targeted Anti-Cancer Therapeutics","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W2489070953","display_name":"Resistance to Proteasome Inhibitors in Cancer"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034020009","display_name":"Francesca Cottini","orcid":"https://orcid.org/0000-0001-8676-7840","observed_orcids":["https://orcid.org/0000-0001-8676-7840"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francesca Cottini","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064544139","display_name":"Anna Guidetti","orcid":"https://orcid.org/0000-0002-4195-6397","observed_orcids":["https://orcid.org/0000-0002-4195-6397"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Guidetti","raw_affiliation_strings":["Universit\u00e0 degli Studi di Milano, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 degli Studi di Milano, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063716448","display_name":"Claudia Paba Prada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudia Paba Prada","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091207345","display_name":"Teru Hideshima","orcid":"https://orcid.org/0000-0003-2939-6224","observed_orcids":["https://orcid.org/0000-0003-2939-6224"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teru Hideshima","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087031787","display_name":"Michelle E. Maglio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Maglio","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037996029","display_name":"Cindy Varga","orcid":"https://orcid.org/0000-0003-4882-5581","observed_orcids":["https://orcid.org/0000-0003-4882-5581","https://orcid.org/0009-0004-8066-6781"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cindy Varga","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006765393","display_name":"Dharminder Chauhan","orcid":"https://orcid.org/0000-0002-5548-6138","observed_orcids":["https://orcid.org/0000-0002-5548-6138"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dharminder Chauhan","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049711954","display_name":"Jacob P. Laubach","orcid":"https://orcid.org/0000-0001-7565-2052","observed_orcids":["https://orcid.org/0000-0001-7565-2052"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob Laubach","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Division of Hematologic Malignancy, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5043526996"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":4.086,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.92941176,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":null,"issue":null,"first_page":"47","last_page":"80"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8479999899864197},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9879999756813049},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":1.0},{"id":"https://openalex.org/keywords/ixazomib","display_name":"ixazomib","score":0.9710000157356262},{"id":"https://openalex.org/keywords/oprozomib","display_name":"oprozomib","score":0.984000027179718},{"id":"https://openalex.org/keywords/marizomib","display_name":"marizomib","score":1.0},{"id":"https://openalex.org/keywords/endoplasmic-reticulum-stress","display_name":"endoplasmic reticulum stress","score":0.8669999837875366},{"id":"https://openalex.org/keywords/protein-overload","display_name":"protein overload","score":0.8519999980926514},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.781000018119812},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.843999981880188}],"concepts":[{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.7459149360656738},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7378643751144409},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47965601086616516},{"id":"https://openalex.org/C57473165","wikidata":"https://www.wikidata.org/wiki/Q7315604","display_name":"Resistance (ecology)","level":2,"score":0.46298280358314514},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3671368956565857},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.36085718870162964},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30042120814323425},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22278252243995667},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.16873356699943542},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-3-319-06752-0_2","doi":"https://doi.org/10.1007/978-3-319-06752-0_2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-3-319-06752-0_2","pdf_url":null,"source":{"id":"https://openalex.org/S4210200539","display_name":"Resistance to targeted anti-cancer therapeutics","issn_l":"2196-5501","issn":["2196-5501","2196-551X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310319972","host_organization_name":"Springer International Publishing","host_organization_lineage":["https://openalex.org/P4310319972","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer International Publishing","Springer Nature"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Resistance to Targeted Anti-Cancer Therapeutics","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":102,"referenced_works":["https://openalex.org/W9899198","https://openalex.org/W1496131048","https://openalex.org/W1513849811","https://openalex.org/W1583113866","https://openalex.org/W1600462418","https://openalex.org/W1929646883","https://openalex.org/W1963899781","https://openalex.org/W1964602059","https://openalex.org/W1965344560","https://openalex.org/W1969574218","https://openalex.org/W1969648097","https://openalex.org/W1969894269","https://openalex.org/W1972271863","https://openalex.org/W1976489571","https://openalex.org/W1978032094","https://openalex.org/W1980471295","https://openalex.org/W1986297232","https://openalex.org/W1996891145","https://openalex.org/W1997070878","https://openalex.org/W1998351143","https://openalex.org/W2000724093","https://openalex.org/W2006170651","https://openalex.org/W2010163650","https://openalex.org/W2012052968","https://openalex.org/W2013370486","https://openalex.org/W2016274355","https://openalex.org/W2017937681","https://openalex.org/W2021242983","https://openalex.org/W2028195916","https://openalex.org/W2039723321","https://openalex.org/W2040146122","https://openalex.org/W2041622856","https://openalex.org/W2050991415","https://openalex.org/W2051517030","https://openalex.org/W2052169053","https://openalex.org/W2052645281","https://openalex.org/W2064451393","https://openalex.org/W2068331698","https://openalex.org/W2072950603","https://openalex.org/W2073782339","https://openalex.org/W2079167171","https://openalex.org/W2079751395","https://openalex.org/W2080691032","https://openalex.org/W2082450387","https://openalex.org/W2084925682","https://openalex.org/W2085379506","https://openalex.org/W2085431272","https://openalex.org/W2089311432","https://openalex.org/W2090156221","https://openalex.org/W2090926709","https://openalex.org/W2095026025","https://openalex.org/W2096207943","https://openalex.org/W2100165190","https://openalex.org/W2100510340","https://openalex.org/W2101035019","https://openalex.org/W2104039873","https://openalex.org/W2104244233","https://openalex.org/W2108075231","https://openalex.org/W2108235071","https://openalex.org/W2114925009","https://openalex.org/W2119528020","https://openalex.org/W2122597368","https://openalex.org/W2123781000","https://openalex.org/W2127760782","https://openalex.org/W2129890171","https://openalex.org/W2131394075","https://openalex.org/W2134864772","https://openalex.org/W2134902298","https://openalex.org/W2135015504","https://openalex.org/W2137941402","https://openalex.org/W2139337843","https://openalex.org/W2140579395","https://openalex.org/W2149761960","https://openalex.org/W2154932260","https://openalex.org/W2155033951","https://openalex.org/W2155947749","https://openalex.org/W2156748957","https://openalex.org/W2158608759","https://openalex.org/W2162468902","https://openalex.org/W2162648910","https://openalex.org/W2163495162","https://openalex.org/W2166427186","https://openalex.org/W2168813385","https://openalex.org/W2169249834","https://openalex.org/W2169774815","https://openalex.org/W2172026936","https://openalex.org/W2172122039","https://openalex.org/W2180080905","https://openalex.org/W2184165601","https://openalex.org/W2275490491","https://openalex.org/W2329072188","https://openalex.org/W2345527859","https://openalex.org/W2391191862","https://openalex.org/W2398639705","https://openalex.org/W2412876769","https://openalex.org/W2507153809","https://openalex.org/W2579459609","https://openalex.org/W2979316059","https://openalex.org/W2981550333","https://openalex.org/W4251280919","https://openalex.org/W4285719527","https://openalex.org/W4293021319"],"related_works":["https://openalex.org/W3184357652","https://openalex.org/W3032840474","https://openalex.org/W3204774999","https://openalex.org/W4401634715","https://openalex.org/W3086493405","https://openalex.org/W2052840623","https://openalex.org/W2484248547","https://openalex.org/W2801317832","https://openalex.org/W2975343753","https://openalex.org/W3029266790"],"abstract_inverted_index":null,"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}